Translational Development Acquisition Corp. · NASDAQ:TDAC

Linden Advisors LP reported a 6.70% stake in Translational Development Acquisition Corp. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 14, 2026

Linden Advisors LP reported a 6.70% stake in Translational Development Acquisition Corp., 1,150,000 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).

Stake
6.70%
Shares
1,150,000
Intent
Passive
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
Linden Capital L.P.6.40%1,109,668
Linden GP LLC6.40%1,109,668
Linden Advisors LP6.70%1,150,000
Siu Min Wong6.70%1,150,000

Source

View original at SEC

Related